CBD Regulations Could Lead Canada to Dominate CBD Oil Market Globally

How Bill C 45 Regulations Can Impact Hemp and Medical Cannabis Markets

CBD oil is the acronym for cannabidiol oil, a natural component of industrial cannabis or hemp. CBD oil is cannabis oil with a significant content of cannabidiol. It is made from the flowers, leaves and stalks of hemp and not from its seeds like hemp oil. CBD oil (contains less than .3% THC) does not have the intoxicating effects of marijuana due to high THC levels. Hemp oil contains less than 25 parts per million in CBD, while CBD oil can be up to 15% CBD.

The Canadian cannabis / CBD oil market has been increasing so much so that it tripled in sales since September 2016. However, many Canadian licensed producers are not even in the process of making cannabis / CBD oil, as they are not yet permitted to sell oils.

Canadian hemp currently can be used only for seed and fiber, with the leaves and flower unusable for CBD extraction without a special license from Health Canada. The proposed hemp regulations in Canada’s larger marijuana plan – expected to become law the summer of 2018 – would also allow hemp farmers to sell the flower and leaves to licensed processors in the medical cannabis market.

What is the CBD Oil Market Growth?

By removing hemp-derived CBD from the list of controlled substances in Canada, an action that could happen separately from expected regulations authorizing recreational marijuana, this is leading companies to gamble that new regulations could allow Canada to dominate the CBD oil market globally.

The Hemp Business Journal reports that the CBD market is growing at a rate of 30% per annum, and forecasts that sales of CBD Oils from cannabis are expected to reach $1,650,000,000, or 79% of the Total CBD Market of $2,100,000,000 by 2020.

What is CBD Oil?

CBD oil is extracted from cannabis plants for cannabinoid and these are also receptors in humans that regulate mood, pain sensation, appetite and memory. These receptors can be activated by endocannabinoids (produced by the human body) as well as by plant cannabinoids (like those found in hemp or cannabis), and they’re grouped in two main categories: CB1 and CB2.

CB1 receptors are found mostly in the central nervous system, and in smaller numbers in the liver, kidneys and lungs, while CB2 receptors are part of the immune system and found in the hematopoietic blood cells as well. CB1 play a role in the production and release of neurotransmitters, cannabis products that exert psychoactive effects stimulating these receptors.

What Are the Medical Benefits of CBD Oil?

CBD oil has strong anti-carcinogenic, anti-inflammatory and anti-convulsive properties, and is not a psychoactive cannabinoid like THC. Studies are also showing CBD as a safe and effective antimicrobial molecule when battling bacterial infections like MRSA, Clostridium difficile and others.

As bacteria infections are becoming increasingly resistant to pharmaceutical antibiotics, CBD oil is an opportunity for healing not fully explored. CBD oil could even act as a neuroprotective agent, may reduce anxiety and have antidepressant effects.

CBD oil could be modified to fit different receptors to treat illness such as diabetes, atherosclerosis and cardiovascular disease. With an aging population world-wide, the Canadian medical cannabis market is forecasted to grow from $6 billion in 2017 to $8 billion by 2010 to meet market demands. In Canada, the overall cannabis market is estimated to grow to $21.8 billion by 2020. https://www.biv.com/article/2017/10/opportunities-cannabis/

For more information about the medical cannabis and CBD oil market, visit Health Canada:


Contact Us to Get Your CBD Oil Company Online

Cana Agency Shop

Cana.Agency is owned and operated by Liza J. Lee Inc. DBA Cana.Agency